Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,270 Cr
down ₹21.5 Cr vs Mar 2022
- Stocks held
- 24
- unchanged
- Top 10 weight
- 69.3%
- of the portfolio in its ten largest
- Cash & debt
- 0.6%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 14
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In April 2022 it disclosed 24 stocks worth ₹1,270 Cr, down ₹21.5 Cr from Mar 2022. Its largest positions were Sun Pharmaceutical Industries Limited (14.9%), Cipla Limited (9.3%), Max Healthcare Institute Limited (8.1%); the ten largest together made up 69.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 55.4% of its equity. Cash and debt stood at 0.6%. Compared with Mar 2022 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
9%
Holds more cash than 9% of peers
What these mean: concentration · cash
Holdings in April 2022
Download CSVEvery line the fund disclosed, with the change against Mar 2022. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 14.87% | up 0.47 pts | ₹189 Cr | up ₹2.8 Cr | Added |
| Cipla Limited | 9.35% | down 0.24 pts | ₹119 Cr | down ₹5.1 Cr | Trimmed |
| Max Healthcare Institute Limited | 8.07% | up 0.94 pts | ₹102 Cr | up ₹10.4 Cr | Added |
| Apollo Hospitals Enterprise Limited | 6.72% | down 0.17 pts | ₹85.3 Cr | down ₹3.6 Cr | Trimmed |
| IPCA Laboratories Limited | 6.29% | down 0.23 pts | ₹79.9 Cr | down ₹4.3 Cr | Trimmed |
| Procter & Gamble Health Limited | 5.54% | up 0.63 pts | ₹70.4 Cr | up ₹6.9 Cr | Added |
| Dr. Reddy's Laboratories Limited | 5.45% | down 0.12 pts | ₹69.2 Cr | down ₹2.7 Cr | Trimmed |
| Lupin Limited | 5.04% | up 0.07 pts | ₹64 Cr | down ₹21 L | Held |
| Alkem Laboratories Limited | 4.30% | down 0.41 pts | ₹54.6 Cr | down ₹6.2 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 3.67% | up 0.22 pts | ₹46.6 Cr | up ₹2 Cr | Added |
| Indoco Remedies Limited | 3.37% | up 0.09 pts | ₹42.7 Cr | up ₹38 L | Added |
| Intuitive Surgical Inc | 2.70% | down 0.68 pts | ₹34.3 Cr | down ₹9.3 Cr | Trimmed |
| Globus Medical Inc | 2.67% | down 0.27 pts | ₹33.9 Cr | down ₹4 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.43% | down 0.05 pts | ₹30.9 Cr | down ₹1.2 Cr | Trimmed |
| Abiomed Inc | 2.31% | down 0.36 pts | ₹29.3 Cr | down ₹5.2 Cr | Trimmed |
| Syngene International Limited | 2.29% | up 0.14 pts | ₹29.1 Cr | up ₹1.4 Cr | Added |
| Abbott Laboratories | 2.16% | down 0.07 pts | ₹27.4 Cr | down ₹1.4 Cr | Trimmed |
| Aarti Drugs Limited | 1.70% | up 0.14 pts | ₹21.6 Cr | up ₹1.5 Cr | Added |
| Alembic Pharmaceuticals Limited | 1.67% | up 0.11 pts | ₹21.2 Cr | up ₹1.1 Cr | Added |
| Narayana Hrudayalaya Limited | 1.56% | down 0.51 pts | ₹19.8 Cr | down ₹6.9 Cr | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.53% | down 0.25 pts | ₹19.4 Cr | down ₹3.6 Cr | Trimmed |
| MedPlus Health Services Limited | 1.50% | down <0.01 pts | ₹19.1 Cr | down ₹38 L | Trimmed |
| Illumina Inc | 1.50% | down 0.23 pts | ₹19 Cr | down ₹3.3 Cr | Trimmed |
| Unichem Laboratories Limited | 1.40% | up 0.08 pts | ₹17.8 Cr | up ₹70 L | Added |
| Kovai Medical Center and Hospital Limited | 1.30% | up 0.08 pts | ₹16.5 Cr | up ₹79 L | Added |
| Cash, TREPS & receivables | 0.62% | up 0.64 pts | ₹7.8 Cr | up ₹8.1 Cr | Added |
What changed, Mar 2022 to Apr 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Max Healthcare Institute Limitedup ₹10.4 Cr (+0.94% pts)
- Procter & Gamble Health Limitedup ₹6.9 Cr (+0.63% pts)
- Sun Pharmaceutical Industries Limitedup ₹2.8 Cr (+0.47% pts)
- Vijaya Diagnostic Centre Limitedup ₹2 Cr (+0.22% pts)
- Aarti Drugs Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2022, the weight rose most in Pharmaceuticals & Biotechnology (+0.6 pts) and Healthcare Services (+0.2 pts), and fell most in Healthcare Equipment & Supplies (−0.9 pts).
- Pharmaceuticals & Biotechnology54.7% → 55.4%+0.6 pts
- Healthcare Services27.8% → 28.0%+0.2 pts
- Pharmaceuticals7.0% → 7.1%+0.1 pts
- Healthcare Equipment & Supplies6.4% → 5.5%−0.9 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2019 | Apr 2021 | Oct 2021 | Jan 2022 | Mar 2022 | Apr 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.3% | 63.1% | 58.7% | 54.0% | 54.7% | 55.4% |
| Healthcare Services | 14.8% | 21.6% | 25.4% | 29.3% | 27.8% | 28.0% |
| Pharmaceuticals | 12.6% | 6.9% | 7.0% | 7.0% | 7.0% | 7.1% |
| Healthcare Equipment & Supplies | — | 5.4% | 6.3% | 5.5% | 6.4% | 5.5% |
| Insurance | 2.3% | 3.0% | 2.5% | 2.6% | 2.5% | 2.5% |
| Retailing | — | — | — | 1.6% | 1.5% | 1.5% |
Allocation in Apr 2022change vs Mar 2022
- Pharmaceuticals & Biotechnology (9)55.4%▲ 0.6 pts
- Healthcare Services (8)28.0%▲ 0.2 pts
- Pharmaceuticals (3)7.1%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Apr 2022
0.6%
▲ 0.6 pts vs Mar 2022
- Cash alone
- 0.6%
- cash and net receivables
- A year earlier
- 6.4%
- Apr 2021 · now ▼ 5.8 pts
- Last 12 months
- −0.3% – 4.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.